Actively Recruiting
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Led by Prof. Dr. Paul Brinkkoetter · Updated on 2025-09-17
500
Participants Needed
12
Research Sites
782 weeks
Total Duration
On this page
Sponsors
P
Prof. Dr. Paul Brinkkoetter
Lead Sponsor
G
German Research Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
In a monocentric, later multicentric prospective approach the FOrMe registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry) aims to generate a longitudinal cohort of 150 pediatric cases of idiopathic nephrotic syndrome and 350 adult cases of biopsy-proven Minimal Change Disease (MCD) or Focal and Segmental Glomerular Sclerosis (FSGS) over 10 years. The registry will provide a repository for biomaterials such as blood samples, DNA, urine, feces, and tissue biopsies that will be accessible to collaborators to facilitate future research on pathogenesis, diagnostics, and treatment.
CONDITIONS
Official Title
The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
Who Can Participate
Eligibility Criteria
You may qualify if you...
Inclusion Criteria (cohort A):
- written informed consent
- 17 or less years of age
- idiopathic nephrotic syndrome
Inclusion Criteria (cohort B):
- written informed consent
- older or equal to 18 years of age
- biopsy-proven primary or secondary FSGS or MCD or biopsy-proven recurrence of disease in kidney transplant.
Exclusion Criteria (both cohorts):
- Prior kidney transplant without biopsy-proven recurrence
- A clinical diagnosis of other glomerular disease resulting in secondary MCD or FSGS as judged by the treating physicians.
- Refusal to provide written informed consent
- (Anticipated) incompliance with visit schedule
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany, 50937
Actively Recruiting
2
Uniklinik RWTH Aachen
Aachen, Germany, 52074
Not Yet Recruiting
3
Charité University Hospital
Berlin, Germany
Actively Recruiting
4
Kindernierenzentrum Bonn
Bonn, Germany, 53127
Actively Recruiting
5
Kindernephrologie Dachau
Dachau, Germany, 85221
Actively Recruiting
6
University Hospital Erlangen
Erlangen, Germany
Not Yet Recruiting
7
University Hospital Essen
Essen, Germany, 45147
Actively Recruiting
8
University Hospital Heidelberg
Heidelberg, Germany, 69120
Actively Recruiting
9
Klinikum St. Georg
Leipzig, Germany, 04129
Actively Recruiting
10
University Hospital Marburg
Marburg, Germany
Actively Recruiting
11
University Hospital Münster
Münster, Germany
Actively Recruiting
12
Klinikum Stuttgart
Stuttgart, Germany, 70174
Actively Recruiting
Research Team
P
Paul T Brinkkoetter, MD
CONTACT
L
Linus A Voelker, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here